Summarizing historical information on controls in clinical trials

样本量测定 临床试验 统计 样品(材料) 随机对照试验 计算机科学 计量经济学 医学 数学 内科学 化学 色谱法
作者
Beat Neuenschwander,Gorana Capkun-Niggli,Michael Branson,David J. Spiegelhalter
出处
期刊:Clinical Trials [SAGE Publishing]
卷期号:7 (1): 5-18 被引量:294
标识
DOI:10.1177/1740774509356002
摘要

Historical information is always relevant when designing clinical trials, but it might also be incorporated in the analysis. It seems appropriate to exploit past information on comparable control groups.Phase IV and proof-of-concept trials are used to discuss aspects of summarizing historical control data as prior information in a new trial. The importance of a fair assessment of the similarity of control parameters is emphasized.The methodology is meta-analytic-predictive. Heterogeneity of control parameters is expressed via the between-trial variation, which is the key parameter determining the prior effective sample size and its upper bound (prior maximum sample size).For a Phase IV trial (930 control patients in 11 historical trials) between-trial heterogeneity was fairly small, resulting in a prior effective sample size of approximately 90 patients. For a proof-of-concept trial (363 patients in four historical trials) heterogeneity was moderate to substantial, resulting in a prior effective sample size of approximately 20. For another proof-of-concept trial (14 patients in one historical trial), assuming substantial heterogeneity implied a prior effective sample size of 7. The prior effective sample size can only be large if the amount of historical data is large and between-trial heterogeneity is small. The prior effective sample size is bounded by the prior maximum sample size (ratio of within- to between-trial variance), irrespective of the amount of historical data.The meta-analytic-predictive approach assumes exchangeability of control parameters across trials. Due to the difficulty to quantify between-trial variability, sensitivity of conclusions regarding assumptions and type of inference should be assessed.The use of historical control information is a valuable option and may lead to more efficient clinical trials. The proposed approach is attractive for nonconfirmatory trials, but under certain circumstances extensions to the confirmatory setting could be envisaged as well.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
savona7发布了新的文献求助10
1秒前
lizhiqian2024发布了新的文献求助10
1秒前
viny发布了新的文献求助30
2秒前
3秒前
3秒前
FFFFcom完成签到,获得积分10
8秒前
8秒前
许是城陌发布了新的文献求助10
9秒前
10秒前
11秒前
傻傻的从梦完成签到 ,获得积分10
12秒前
14秒前
qqsaosa发布了新的文献求助20
14秒前
15秒前
16秒前
16秒前
niuma发布了新的文献求助10
16秒前
viny完成签到,获得积分10
17秒前
橙子完成签到,获得积分10
17秒前
19秒前
李健应助科研通管家采纳,获得10
19秒前
19秒前
NexusExplorer应助高贵世德采纳,获得10
19秒前
丘比特应助科研通管家采纳,获得10
19秒前
FashionBoy应助科研通管家采纳,获得10
20秒前
无花果应助科研通管家采纳,获得10
20秒前
当当康康发布了新的文献求助50
20秒前
赘婿应助科研通管家采纳,获得10
20秒前
20秒前
闪闪靖荷完成签到,获得积分10
20秒前
英姑应助科研通管家采纳,获得10
20秒前
20秒前
20秒前
深情安青应助科研通管家采纳,获得10
20秒前
20秒前
打打应助科研通管家采纳,获得10
21秒前
所所应助科研通管家采纳,获得10
21秒前
Lucas应助科研通管家采纳,获得10
21秒前
080206ws发布了新的文献求助10
21秒前
21秒前
高分求助中
Markov Chain Monte Carlo 10000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Common Foundations of American and East Asian Modernisation: From Alexander Hamilton to Junichero Koizumi 5000
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
Discerning Saints: Moralization of Intrinsic Motivation and Selective Prosociality at Work 500
Handbuch Trainingswissenschaft – Trainingslehre 500
Additive Manufacturing Design and Applications (ASM Handbook, Volume 24A) 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7584626
求助须知:如何正确求助?哪些是违规求助? 9163194
关于积分的说明 19610092
捐赠科研通 7166370
什么是DOI,文献DOI怎么找? 3266472
关于科研通互助平台的介绍 2431470
邀请新用户注册赠送积分活动 2258135